These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 4707380

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)].
    Schneider WH, Schmid R, Spona J.
    Wien Klin Wochenschr; 1981 Oct 16; 93(19):601-4. PubMed ID: 6798765
    [Abstract] [Full Text] [Related]

  • 4. [Effects of a cycle-regulating 2-phase preparation on peripheral and central cycle function].
    Schneider WH, Spona J, Matt K.
    Ther Umsch; 1973 Jul 16; 30(7):516-23. PubMed ID: 4720331
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Electroencephalographic changes in women treated with contraceptive steroids.
    Gautray JP, Eberhard A, Jalivet A, Leygonie G.
    Basic Life Sci; 1974 Jul 16; 4(PART A):385-97. PubMed ID: 4447577
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Metabolic effects of a combination of dl-norgestrel and ethinylestradiol in humans.
    Gerhards E, Lachnit U, Gaude R, Schillinger E.
    Arzneimittelforschung; 1973 Jun 16; 23(6):779-84. PubMed ID: 4740760
    [No Abstract] [Full Text] [Related]

  • 11. Low dose lynestrenol as a contraceptive influence on ovarian function.
    Järvinen PA, Ylikorkala O, Ylöstalo P.
    Ann Clin Res; 1974 Apr 16; 6(2):109-14. PubMed ID: 4837883
    [No Abstract] [Full Text] [Related]

  • 12. Effects of a synthetic estrogen-progestogen agent on urinary gonadotropin levels of FSA and LH using a radioimmunologic method.
    Forleo R, Vegna G, Pala A.
    Acta Eur Fertil; 1972 Jun 16; 3(2):159-76. PubMed ID: 4679575
    [No Abstract] [Full Text] [Related]

  • 13. Mode of action of DL-norgestrel and ethinylestradiol combination in postcoital contraception.
    Ling WY, Robichaud A, Zayid I, Wrixon W, MacLeod SC.
    Fertil Steril; 1979 Sep 16; 32(3):297-302. PubMed ID: 488410
    [Abstract] [Full Text] [Related]

  • 14. Elevation of serum prolactin during application of oral contraceptives.
    Dericks-Tan JS, Taubert HD.
    Contraception; 1976 Jul 16; 14(1):1-8. PubMed ID: 975808
    [No Abstract] [Full Text] [Related]

  • 15. The menstrual cycle after withdrawal of oral contraceptives with particular reference to return of ovulation.
    Jordan K.
    Mater Med Pol; 1975 Jul 16; 7(2):126-32. PubMed ID: 1142823
    [No Abstract] [Full Text] [Related]

  • 16. [Radioimmunologic studies on serum progesterone in normal and induced menstrual cycle].
    Gitsch E, Spona J.
    Geburtshilfe Frauenheilkd; 1973 Apr 16; 33(4):303-9. PubMed ID: 4736277
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Norgestrel and ethynyl estradiol: a new low-dosage oral agent for fertility control.
    Rice-Wray E, Avila C, Gutiérrez J.
    Obstet Gynecol; 1968 Mar 16; 31(3):368-74. PubMed ID: 5639191
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.